Court endorses interim injunction on generic drugs' fabrication case

Recently, Seoul District Court gave the green light to an interim injunction filed by six pharmaceutical companies against the Korea Food and Drug Administration's administrative order to retract approval for 17 problematic generic drugs, banning pharmaceutical companies from manufacturing and selling them in September.

The court said in a ruling that the damage brought forth by the plaintif...